Pearl River to lose millions in Pfizer plant taxes

Local officials in Pearl River, N.Y., are lamenting the impending loss of a Pfizer plant there, considering that the company facility makes up 10 percent of the tax base and pays some $20 million in school-district taxes annually. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.